Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 16/20 | 0.65 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.49 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.49 |
| ▸ | DPP7 | Q9UHL4 | 5/20 | 0.46 |
| ▸ | PREP | P48147 | 1/20 | 0.45 |
| ▸ | FAP | Q12884 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL712816 | 0.91 | DPP4 (0.59) | DPP4DPP8DPP9DPP7PREP | |
| SCHEMBL6238524 | 0.79 | DPP4 (1.00) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL6238520 | 0.79 | DPP4 (1.00) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL5647937 | 0.79 | DPP4 (1.00) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL5647935 | 0.79 | DPP4 (1.00) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL6751530 | 0.78 | DPP4 (0.60) | DPP4DPP8DPP9DPP7PREP | |
| Hydrochloric Acid SCHEMBL5652236 | 0.78 | DPP4 (0.97) | DPP4DPP8DPP9DPP7FAP | |
| Hydrochloric Acid SCHEMBL5652234 | 0.78 | DPP4 (0.97) | DPP4DPP8DPP9DPP7FAP | |
| Hydrochloric Acid SCHEMBL3601691 | 0.78 | DPP4 (0.97) | DPP4DPP8DPP9DPP7FAP | |
| Hydrochloric Acid SCHEMBL5049190 | 0.78 | DPP4 (0.97) | DPP4DPP8DPP9DPP7FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100081701-A1 | FAP inhibitors | VANTIA LIMITED (GB) | 2010-04-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081701-A1 | FAP inhibitors | FAP, APC, SERPINB1 | DPP4 256/4885DPP8 227/4885DPP9 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.